Latest Update (as of September 13, 2026): On August 20, 2026, Abbott announced a settlement of approximately $670 million to resolve the high-profile Gill case — the $495 million Missouri verdict the company had been appealing — along with NEC claims brought on behalf of roughly 2,000 additional infants. The Missouri Court of Appeals had affirmed the Gill verdict in May 2026, and Abbott agreed to drop further appeals as part of the deal. Abbott has not admitted liability and still faces roughly 1,000–1,700 additional NEC lawsuits nationwide, including more than 800 consolidated in MDL 3026 before Judge Rebecca Pallmeyer in the Northern District of Illinois. Separately, Mead Johnson has not settled and remains in active litigation, including a defense verdict it won in a Missouri trial in July 2026.
Last updated: September 2026
Thousands of families are pursuing NEC lawsuit claims against the makers of Similac and Enfamil after premature infants developed a life-threatening bowel disease in NICUs across the country. This litigation has produced multimillion-dollar jury verdicts and is pushing toward broader settlements in 2026.
The core accusation is straightforward. Abbott Laboratories and Mead Johnson knew their cow’s milk-based formula products carried elevated NEC risks for premature babies. They sold those products to hospitals without adequate warnings.
In this article, you will learn exactly where the litigation stands in 2026, who qualifies, how much families could receive, and what the path forward looks like. Every major question gets answered here, in plain language.
NEC Lawsuit Update 2026: Where Things Stand Right Now
The NEC lawsuit in 2026 is at a turning point, with bellwether trials behind us and mounting pressure on both defendants to move toward resolution.
MDL 3026, formally titled “In re: Preterm Infant Nutrition Products Liability Litigation,” is consolidated in the Northern District of Illinois. Judge Rebecca Pallmeyer has been presiding over this massive case load.
Early bellwether trials produced enormous plaintiff verdicts. Those verdicts sent a clear signal to Abbott and Mead Johnson that juries are willing to hold formula makers accountable. The defense strategy has shifted in response.
| Case Phase | Status in 2026 |
|---|---|
| MDL Consolidation | Active, Northern District of Illinois |
| Bellwether Trials | Completed; mixed but largely plaintiff-favorable verdicts |
| Settlement Negotiations | Ongoing discussions, no global deal confirmed as of early 2026 |
| New Case Filings | Continuing as statute of limitations awareness grows |
| Expected Resolution Window | Late 2026 to 2027 |
Both companies are appealing certain trial outcomes. At the same time, plaintiff attorneys report active behind-the-scenes settlement conversations. 2026 may be the year this litigation starts to resolve at scale.
NEC Lawsuit Payout 2026: What Families Can Realistically Expect
NEC lawsuit payouts in 2026 range from hundreds of thousands of dollars to over $100 million, depending on the severity of the injury and whether the case goes to trial or settles.
Jury verdicts have been staggering. In 2023, a St. Louis jury awarded $60 million against Mead Johnson in a single case. Another jury awarded over $495 million in a separate verdict. These are trial outcomes, not settlement figures.
Individual settlement amounts, when they come, are expected to be significantly lower. Mass tort settlements typically compensate claimants based on a tiered system tied to the severity of the child’s diagnosis and documented harm.
| Compensation Type | Estimated Range |
|---|---|
| Death of infant (wrongful death claim) | $500,000 to $10 million+ |
| Severe NEC with surgery and long-term damage | $250,000 to $5 million |
| NEC diagnosis without surgical intervention | $50,000 to $500,000 |
| Global settlement pool (estimated, unconfirmed) | Billions across all claimants |
These are not guaranteed numbers. Settlement amounts depend on the strength of evidence, documentation, and negotiated terms. But the trajectory of jury verdicts gives plaintiff families real leverage in 2026.
Key Takeaway: Jury verdicts in NEC cases have reached hundreds of millions of dollars, creating significant pressure on defendants to settle thousands of pending claims.
Who Qualifies for the NEC Lawsuit?
A family may qualify for the NEC lawsuit if a premature infant was fed cow’s milk-based formula in a NICU and was later diagnosed with necrotizing enterocolitis.
The qualifying criteria center on three things: the baby’s prematurity, the formula received, and the NEC diagnosis. All three need to be present. Documentation from the hospital is the foundation of any claim.
Here is a quick breakdown of who typically qualifies:
- The infant was born premature (generally before 37 weeks gestation)
- The infant was fed Similac, Enfamil, or another cow’s milk-based fortifier in a NICU setting
- The infant was diagnosed with NEC
- The diagnosis resulted in serious harm, including surgery, long-term intestinal damage, or death
- The incident falls within the applicable statute of limitations window
Families whose children survived NEC with lasting damage can file. Families who lost a child to NEC can file a wrongful death claim. Both paths are open in 2026.
NEC Lawsuit Settlements 2026: Are Companies Paying Out?
No announced global settlement exists as of early 2026, but individual case settlements are happening quietly behind the scenes.
This is how mass tort litigation typically works. Companies don’t announce a single massive payout date. They negotiate with plaintiff law firms on batches of cases. Some families have already received confidential settlements. The full picture won’t emerge until a broader resolution is announced.
The key driver pushing toward settlement in 2026 is the weight of jury verdicts. When juries keep awarding $60 million to $500 million per case, a global settlement starting to look more attractive to Abbott and Mead Johnson than continued trial exposure.
| Settlement Signal | What It Means |
|---|---|
| Large jury verdicts in plaintiff favor | Increased settlement pressure on defendants |
| Ongoing MDL proceedings | Cases are managed collectively, which speeds resolution |
| No global deal announced yet | Individual case settlements are happening quietly |
| New cases still being filed | Resolution timeline extends as new plaintiffs join |
If a global settlement is reached, claimants who have already filed will be in a far better position than those who wait.
NEC Lawsuit Eligibility Requirements Explained
NEC lawsuit eligibility comes down to documented medical proof linking a premature infant’s NEC diagnosis to cow’s milk formula received in a NICU.
You cannot file based on suspicion alone. The records need to show what the baby was fed. NICU discharge records, feeding logs, and medical charts are the evidence that matters.
Here are the core eligibility requirements in plain terms:
- Infant’s birth: Premature birth, typically before 37 weeks
- Formula type: Cow’s milk-based product (Similac Special Care, Enfamil Premature, Enfamil Human Milk Fortifier, or similar)
- Location of feeding: A NICU or hospital setting, not home use
- Diagnosis: Confirmed NEC diagnosis, preferably documented by a treating physician
- Outcome: Serious injury including surgery, bowel removal, intestinal complications, developmental harm, or death
- Timing: Diagnosis must fall within the statute of limitations for your state
Families who used donor breast milk exclusively, or whose infants were not premature, typically do not qualify. The link has to be specifically to cow’s milk formula in a premature NICU context.
Key Takeaway: Eligibility for the NEC lawsuit requires documented proof that a premature infant was fed cow’s milk formula in a NICU and subsequently diagnosed with NEC.
What Is the NEC Baby Formula Lawsuit?
The NEC baby formula lawsuit is a product liability litigation alleging that Similac and Enfamil cow’s milk-based products caused necrotizing enterocolitis in premature infants, and that manufacturers knew about the risk but failed to warn hospitals and families.
NEC is a devastating condition. It destroys intestinal tissue. In premature babies, it can kill within hours. The mortality rate for severe NEC cases ranges from 15% to 30%. Survivors often face life-long digestive complications.
The lawsuits argue that research linking cow’s milk formula to elevated NEC risk in preterm infants existed for decades. Abbott and Mead Johnson had that research. They chose not to change their labeling or practices. That failure is the legal basis for these claims.
Think of it like a seat belt defect lawsuit. If a company knows a part fails under certain conditions and keeps selling it without a warning, they face liability when someone gets hurt. The same principle applies here, applied to infant nutrition.
Is This a Class Action Lawsuit or Something Else?
The NEC lawsuit is not a traditional class action. It is a mass tort, which is a fundamentally different legal structure that gives each family an individual case.
This distinction matters a lot for compensation. In a class action, one settlement is divided among all members, often resulting in small individual payouts. In a mass tort, each family’s case is evaluated on its own facts, and compensation reflects the specific harm that child suffered.
| Feature | Class Action | Mass Tort (NEC Litigation) |
|---|---|---|
| Individual cases | No, one group case | Yes, each family has their own claim |
| Payout structure | Divided pool, often small | Based on individual harm level |
| Court management | Single judge, group outcome | MDL consolidates but preserves individual claims |
| Best for | Consumer fraud, small uniform losses | Serious personal injury, product liability |
The NEC litigation is managed as an MDL (multidistrict litigation), which means cases are consolidated for pretrial efficiency but remain individual claims for purposes of compensation.
The Similac NEC Lawsuit: What Abbott Faces in 2026
Abbott Laboratories faces thousands of NEC lawsuits tied to its Similac line of premature infant formula products, particularly Similac Special Care.
Abbott is one of the two primary defendants in MDL 3026. Plaintiff claims allege that Similac Special Care and related cow’s milk-based products were marketed to hospitals for use in NICUs without adequate disclosure of NEC risk in preterm infants.
Abbott has contested the scientific link between its products and NEC at every stage. It has invested heavily in expert witnesses and Daubert motions designed to exclude plaintiff experts from testifying at trial.
Despite those efforts, juries have found against Abbott in multiple bellwether cases. The company is appealing several significant verdicts. In 2026, its legal strategy appears to involve fighting cases aggressively at trial while simultaneously exploring what a global settlement would look like.
Bold fact: One Similac-related NEC verdict alone reached approximately $495 million, representing one of the largest product liability verdicts in recent U.S. history involving infant nutrition products.
The Enfamil NEC Lawsuit: What Mead Johnson and Reckitt Face
Mead Johnson Nutrition, a subsidiary of British consumer goods company Reckitt Benckiser, faces NEC lawsuits tied to its Enfamil premature formula and Enfamil Human Milk Fortifier products.
Reckitt acquired Mead Johnson in 2017 for approximately $17 billion. Since then, it has inherited the full weight of this growing litigation. This is a significant corporate liability issue for the parent company, which is based in the United Kingdom.
Like Abbott, Mead Johnson has disputed the scientific claims at the center of these lawsuits. A 2023 St. Louis verdict delivered a $60 million judgment against the company in a single NEC case. That verdict drew national attention.
| Defendant | Parent Company | Key Product(s) |
|---|---|---|
| Mead Johnson Nutrition | Reckitt Benckiser | Enfamil Premature, Enfamil Human Milk Fortifier |
| Abbott Laboratories | Abbott Laboratories (independent) | Similac Special Care, Similac Human Milk Fortifier |
Reckitt has disclosed NEC litigation as a material financial risk in its investor filings. That disclosure alone signals the scale of what the company is facing in courts across the country.
Key Takeaway: Both Abbott and Mead Johnson face massive individual jury verdicts and ongoing MDL proceedings, with no end to new case filings in sight through 2026.
NEC MDL Lawsuit Status: Inside the Federal Proceedings
MDL 3026 is the central federal docket for NEC baby formula litigation, consolidated in the Northern District of Illinois under Judge Rebecca Pallmeyer.
MDL stands for multidistrict litigation. When hundreds or thousands of similar federal lawsuits are filed across the country, courts can consolidate them in one district for pretrial proceedings. This prevents duplicate discovery and creates consistency in rulings.
As of 2026, MDL 3026 contains thousands of cases. New filings are still arriving regularly. The MDL process includes several key phases:
- Discovery phase: Both sides exchange medical records, internal company documents, and expert reports
- Daubert hearings: Judges rule on which expert witnesses can testify at trial
- Bellwether trials: A small number of cases go to trial first as test cases to gauge jury reactions
- Settlement discussions: Results from bellwether trials inform negotiations
- Global resolution or continued trials: The MDL moves toward either a mass settlement or ongoing individual trials
The bellwether phase has produced plaintiff-favorable outcomes. That shifts the leverage toward settlement in 2026 and beyond.
NEC Lawsuit Trial Verdicts: What Juries Have Decided
NEC lawsuit trial verdicts have overwhelmingly favored plaintiff families, with individual jury awards ranging from tens of millions to nearly half a billion dollars.
These are not the final payouts families will receive. Verdicts go through appeals and remittitur processes where judges can reduce awards. But they establish what juries believe this harm is worth.
| Trial | Verdict | Defendant | Year |
|---|---|---|---|
| St. Louis NEC trial | $60 million | Mead Johnson (Reckitt) | 2023 |
| Illinois NEC trial | ~$495 million | Abbott Laboratories | 2023 |
| Additional state court trials | Varied outcomes | Both defendants | 2023-2025 |
| 2026 proceedings | Ongoing | Both defendants | 2026 |
Not every trial has resulted in a plaintiff win. Some juries have sided with the defense. But the overall pattern of large verdicts puts continuous financial and reputational pressure on both companies.
The appeals process means these numbers can change. But the direction is clear. Juries across multiple states have heard the evidence and found the formula makers liable.
Who Are the Defendants: Abbott and Mead Johnson’s Legal Position
The two primary defendants in NEC lawsuits are Abbott Laboratories and Mead Johnson Nutrition, the companies that manufacture and sell the cow’s milk formula products at the center of the litigation.
Both companies have maintained consistent legal positions. They argue that the scientific evidence does not conclusively establish that their products cause NEC. They argue that the medical community has long recommended their products for use in NICUs. They point to institutional knowledge and hospital decision-making as intervening factors.
Their defense strategy has several components:
- Challenge the admissibility of plaintiff expert testimony under the Daubert standard
- Argue that causation evidence is insufficient to hold manufacturers liable
- Point to the absence of FDA warnings or regulatory action against their products
- Argue that hospitals, not formula companies, make feeding decisions in NICUs
These arguments have worked in some trials and failed in others. The inconsistency in outcomes is exactly why mass tort litigation can drag on for years. 2026 is shaping up as a year of significant pressure on both defendants.
Key Takeaway: Abbott and Mead Johnson are contesting liability on both scientific and legal grounds, but a string of major jury verdicts has weakened their trial position entering 2026.
The Science Battle: NEC Lawsuit Evidence and Daubert Rulings
The central scientific dispute in NEC lawsuits is whether cow’s milk-based formula products are a cause of NEC in premature infants, and courts are actively ruling on which expert testimony can be heard by juries.
The Daubert standard governs whether expert witnesses can testify in federal court. Judges act as gatekeepers. They decide if an expert’s methodology is scientifically sound enough to present to a jury. If plaintiff experts get excluded, cases collapse. This is a critical battleground.
Plaintiff experts point to decades of research, including observational studies and the American Academy of Pediatrics’ longstanding preference for donor breast milk in NICUs, as evidence that cow’s milk formula carries elevated NEC risk for premature babies.
Defense experts argue that no randomized controlled trial has definitively proven causation. They argue correlation is not causation. They challenge the quality and design of the studies plaintiff experts cite.
Courts in MDL 3026 have issued rulings on specific expert witnesses. Some plaintiff experts were limited. Some were allowed. The back-and-forth on science is why some bellwether trials have landed differently than others.
In 2026, the science debate continues. But plaintiff experts have survived enough Daubert challenges to keep cases moving toward juries.
Class Action vs. Mass Tort: What Type of Lawsuit Is This?
The NEC lawsuit is a mass tort litigation, not a class action, meaning every family has their own individual case and their own individual compensation based on what their child experienced.
People often use “class action” as a catch-all term for group lawsuits. It isn’t accurate here. The distinction is financially meaningful.
| Question | Class Action Answer | Mass Tort (NEC) Answer |
|---|---|---|
| Does everyone get the same payout? | Usually yes | No, based on individual harm |
| Is each claim separately evaluated? | No | Yes |
| Can one family get millions while another gets less? | Rarely | Yes, routinely |
| How are cases managed in court? | One lead case | MDL consolidates pretrial, keeps individual claims |
| Who benefits most? | Works for widespread small harms | Works for serious physical injuries |
The mass tort structure means the severity of your child’s NEC diagnosis, the quality of your documentation, and the specific facts of your case all directly affect your compensation. Two families in the same MDL can receive very different outcomes.
This is actually better for most NEC families than a class action would be. The harms here are severe, individual, and documented. A tiered individual compensation approach serves these families more fairly.
NEC Lawsuit Statute of Limitations 2026: Don’t Miss Your Window
The statute of limitations for filing an NEC lawsuit varies by state, typically running between 2 and 3 years from the date of injury or the date you reasonably discovered the connection between the formula and NEC.
This deadline is not flexible. Miss it, and your family’s case gets dismissed regardless of how strong the underlying facts are. Thousands of families are learning about these lawsuits for the first time in 2026. That timing matters.
The “discovery rule” is your potential lifeline. In many states, the statute of limitations clock starts when you knew or reasonably should have known that formula caused the NEC, not necessarily when the NEC was diagnosed. If you only recently learned about this litigation, speak with an attorney immediately to assess your window.
| State Scenario | Typical Limitations Period |
|---|---|
| Standard personal injury (most states) | 2 years from injury date |
| Wrongful death claim | 2 to 3 years from death date |
| Discovery rule applied | Clock starts from date of discovery |
| Tolling for minors (some states) | Clock may not start until child turns 18 |
Some states have statutes of repose that can cut off claims even with the discovery rule. The safest move in 2026 is to act now. Waiting is the one thing that can permanently close a valid claim.
Key Takeaway: Statute of limitations deadlines are absolute cutoffs, and families who recently learned about NEC lawsuits in 2026 need to assess their timeline immediately.
How to File an NEC Lawsuit Claim in 2026
Filing an NEC lawsuit claim in 2026 starts with gathering your child’s NICU medical records and contacting a mass tort attorney who handles baby formula NEC cases.
This is not a DIY legal project. NEC cases involve complex scientific evidence, MDL procedures, and aggressive defense teams from two major corporations. Plaintiff attorneys who specialize in this area work on contingency, meaning they take no fee unless you win.
Here is the general process:
Step 1: Gather your documentation
- NICU admission and discharge records
- Feeding logs showing what formula was used
- NEC diagnosis records from the treating physician
- Surgical records if applicable
- Any records of long-term complications or death
Step 2: Contact a mass tort law firm
- Seek out firms with NEC experience and MDL cases already filed
- Initial consultations are free
- Attorneys work on contingency; no upfront cost to you
Step 3: Case evaluation
- Attorney reviews your records
- Confirms eligibility and statute of limitations status
- Files your individual complaint or adds it to an existing MDL filing
Step 4: Discovery and litigation
- Your case becomes part of MDL 3026 or a state court proceeding
- Medical records are exchanged, expert witnesses are retained
- Your case may settle or go to trial depending on the path of the broader litigation
The faster you move in 2026, the better. Settlement funds, when finalized, typically prioritize cases that were filed early.
Frequently Asked Questions
What is the NEC lawsuit about?
The NEC lawsuit targets Abbott Laboratories and Mead Johnson for manufacturing cow’s milk-based formula products that allegedly caused necrotizing enterocolitis in premature infants.
Families claim the companies failed to warn hospitals and parents about the elevated NEC risk for preterm babies.
Thousands of cases are consolidated in federal MDL 3026 in the Northern District of Illinois.
How much money can families get from the NEC lawsuit payout?
NEC lawsuit payouts range from tens of thousands to millions of dollars depending on the severity of the child’s diagnosis and whether the case settles or goes to trial.
Jury verdicts have reached $60 million to nearly $500 million in individual cases.
Settlement amounts are typically lower but are expected to reflect the severity of each child’s harm.
Who qualifies to file an NEC baby formula lawsuit?
Families qualify if a premature infant was fed Similac, Enfamil, or another cow’s milk-based formula in a NICU and was later diagnosed with NEC.
The child must have suffered serious harm such as surgery, bowel damage, long-term complications, or death.
Medical records from the NICU documenting the formula used and the NEC diagnosis are required to file.
What is the current status of the NEC class action lawsuit in 2026?
The NEC litigation is not technically a class action but is managed as a mass tort MDL in federal court.
Bellwether trials have produced major plaintiff verdicts, and settlement negotiations are ongoing as of 2026.
No global settlement has been announced, but the pressure on Abbott and Mead Johnson to resolve thousands of pending claims is intensifying.
What is the statute of limitations for filing an NEC lawsuit?
The statute of limitations for NEC lawsuits typically ranges from 2 to 3 years depending on the state.
The clock may start from the date of injury or from the date you discovered the link between the formula and NEC under the discovery rule.
Families learning about this litigation for the first time in 2026 should consult an attorney immediately to determine whether they are still within the filing window.
The Road Ahead for NEC Families in 2026
The NEC lawsuit is one of the most significant ongoing product liability litigations in the country right now. Billions of dollars in exposure, thousands of affected families, and real jury verdicts have brought this case to a critical moment.
If your premature child was fed Similac or Enfamil in a NICU and developed NEC, your window to act may still be open. But it won’t stay open indefinitely. Statute of limitations deadlines are real, and every month matters.
Gather your NICU records. Contact a mass tort attorney who handles NEC cases. Filing costs you nothing upfront, and the families who act in 2026 are best positioned for compensation when the broader litigation resolves.
